BioMarin Announces Completion of Acquisition of Inozyme
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq futures tumble as Amazon, Intel results deepen AI spending woes
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 57.49 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.49 | 52 Week High | $108.96 | |||
| Open | $57.49 | 52 Week Low | $62.12 | |||
| Day High | $57.49 | P/E | N/A | |||
| Day Low | $57.49 | EPS | $-1.27 | |||
| Volume | 851 | |||||
| (NASDAQ: INZY) | Delayed: 4.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.00 | 52 Week High | $ | |||
| Open | $4.00 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $ | |||
| Volume | 44 | |||||
